1 option
Brand-name Prescription Drug Pricing: Lack Of Therapeutically Equivalent Drugs And Limited Competition May Contribute To Extraordinary Price Increases
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.